IP Verse

Sanofi Biotechnologies Sas vs. Amgen Inc. - ACT_597355/2023

Explore detailed information on the case number ACT_597355/2023 involving Sanofi Biotechnologies Sas, Regeneron Pharmaceuticals Inc. and Amgen Inc., Amgen Gmbh, Amgen Europe B.V., and others which was filed on 10 Jan, 2024.

Case Details

    Case Number:

    ACT_597355/2023

    Patent Number:

    EP3536712

    Filing Date:

    10 Jan, 2024

    Proceeding Type:

    Proceeding

    Action/Application:

    Infringement Action

    Decision Date:

    13 May, 2025

    Plaintiffs:

    • Sanofi Biotechnologies Sas Represented By Niels Holder
    • Regeneron Pharmaceuticals Inc. Represented By Niels Holder

    Defendants:

    • Amgen Inc. Represented By Johannes Heselberger
    • Amgen Gmbh Represented By Johannes Heselberger
    • Amgen Europe B.V. Represented By Johannes Heselberger
    • Amgen Nv Represented By Johannes Heselberger
    • Amgen S.R.L. Represented By Johannes Heselberger
    • Amgen B.V. Represented By Johannes Heselberger
    • Amgen S.A.S. Represented By Johannes Heselberger

    Judges:

    • Andras Kupecz
    • Berenice Thom
    • Ronny Thomas
    • Xavier DORLAND-GALLIOT

    Court Division:

    First Instance, Local Division - Dusseldorf

Case Decision

    Decision Date:

    May 13, 2025

    Decision Document:

More cases involving EP3536712B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 25, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
APL_32765/2025Jul 11, 2025Amgen Europe, Amgen, Amgen, Amgen, Amgen, Amgen, AmgenRegeneron Pharmaceuticals
CC_24999/2024May 3, 2024Amgen Europe B.V., Amgen Inc., Amgen B.V., Amgen S.R.L., Amgen Nv, Amgen Gmbh, Amgen S.A.S.Regeneron Pharmaceuticals Inc.

More cases involving Sanofi Biotechnologies Sas

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 25, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
App_29861/2025Jun 27, 2025Sanofi Biotechnologies, Regeneron Pharmaceuticals -
ORD_16586/2025Apr 4, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen

More cases involving Amgen Inc.

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Sep 25, 2025
Case NumberFiling DatePlaintiffsDefendants
APL_32715/2025Jul 14, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ORD_16586/2025Apr 4, 2025Regeneron Pharmaceuticals, Sanofi BiotechnologiesAmgen, Amgen, Amgen Europe, Amgen, Amgen, Amgen, Amgen
ACT_10334/2025Feb 28, 2025Regeneron Pharmaceuticals Inc., Sanofi Biotechnology SasAmgen S.R.L., Amgen S.A.S., Amgen Nv, Amgen Gmbh, Amgen Inc., Amgen Europe B.V., Amgen B.V.